H-1B sponsorship profile: Candel Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Candel Therapeutics, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2024 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Candel Therapeutics, Inc’s H-1B petitions range from $73,674 at the low end to $77,210 at the high end, with a petition-weighted average of $75,601. That range reflects the mix of occupations the company sponsors, led by Regulatory Affairs Associate (1 petitions at $75,920 avg), followed by Clinical Trial Data Associate and Clinical Research Associate. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Candel Therapeutics, Inc is headquartered in Needham, MA under NAICS code 541714, and places H-1B workers across 2 states, most heavily in MA, OH. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Candel Therapeutics, Inc ranks. By H-1B petition volume, Candel Therapeutics, Inc is #37,433 of 119,880 employers nationally and #1,704 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.